View this email in your browser
CLIC Center for Leading Innovation & Collaboration logo
News Roundup
June 15, 2021
CTSA News            CLIC Updates            CLIC Education            ICYMI            Coordinating Center News
News from around the CTSA Program Consortium

SCTR-supported COVID-19 biorepository yields new insights into IgG antibody responses in patients with and without symptoms

People who successfully fight off COVID-19 without showing symptoms have much higher levels of IgG antibodies against the virus’s spike protein than do patients who were hospitalized with COVID-19, reports a research team led by Shikhar Mehrotra, Ph.D., of the Medical University of South Carolina (MUSC) in a recent issue of iScience.

Podcast episode discusses research into healthy aging of LGBTQ community members

Penn State Clinical and Translational Science Institute released the latest episode of its Engage Podcast discussing research into healthy aging in the LGBTQ community. Britney Wardecker, Ph.D., an assistant professor of nursing at Penn State College of Nursing, discusses her work into understanding the needs and health care preferences of aging LGBTQ community members.

Storytelling and Diversity: Using Your Story to Explore Diversity, Equity, and Inclusivity in Research

In this workshop, members of DC3 will share the journey of creating the event and the lessons learned which has led to further expansion of the resources they are able to provide. After sharing the lessons, they will use guided prompts to allow attendees to explore their own stories to see how your own story affects how they show up in the world and the research community. 

June 16 at 2pm ET

CTSA ReFRAME Call for Proposals

The Scripps Research Translational Institute and drug discovery affiliate Calibr invite proposals for collaborative drug repurposing screens. This translational endeavor aims to partner clinical proficiencies throughout the Clinical and Translational Science Awards (CTSA) network with drug discovery resources. CTSA-affiliated researchers and clinicians who have identified potential drug targets, pathways or screening approaches and are interested in accelerated translation into patients through drug repurposing are encouraged to respond. 

Updates from CLIC  

CLIC Un-Meeting: Exploring the Inclusion of Community Hospitals in Clinical Research

Researchers across the country gathered virtually last month to discuss outreach to community hospitals for recruitment and enrollment into clinical trials at the CLIC-hosted Un-Meeting “Exploring the Inclusion of Community Hospitals in Clinical Research.” The topic, chosen by the National Center for Advancing Translational Sciences (NCATS), was driven by the disconnect between high COVID patient numbers and a low number of people who enrolled in clinical trials during the pandemic. 

CLIC will be scheduling a "next steps" Un-Meeting for the fall of 2021 to continue the conversation. If you are interested in speaking, please contact the Un-Meetings team here: unmeetings@clic-ctsa.orgWe are especially looking for speakers and attendees from community hospitals. Please pass this information along to anyone who might be interested.
CLIC Education

From Brain Disorders to Brain Health: Prevention and Management of Cognitive Decline and Dementia

Check out this free, one-hour continuing medical education (CME) course from the University of Florida CTSI. Through this CME, cognitive health experts provide the latest information on the screening, diagnosis and treatment of mild cognitive impairment and dementia, including referral to specialty care.

Join the CLIC Career Development Community!

ICYMI: News from the Science & Research World


Novavax Covid-19 vaccine highly effective in late-stage trial, long-awaited results show

Novavax’s Covid-19 vaccine was highly effective in preventing symptomatic infections, hospitalizations, and severe illnesses, long-awaited results from the company’s Phase 3 trial, released Monday, revealed. The vaccine was 90% protective against laboratory-confirmed symptomatic infection.

CTSA Program Coordinating Centers' News

Trial Innovation Network logo

TIN overview and getting started quick guide


This guide answers questions such as: 

  • What is the Trial Innovation Network?
  • What makes a good TIN submission?
  • What happens after my TIN submission?
Explore this resource and more in the TIN toolbox
National Center for Data to Health logo

Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)

The N3C article authored by Noha Sharafeldin, MD, PhD, MSc, et al has been published in the Journal of Clinical Oncology. The authors assembled the largest nationally representative cohort of patients with cancer and COVID-19 to date and identified demographic and clinical factors associated with increased all-cause mortality in patients with cancer. 

If you have a story, opportunity, project or event that you'd like included in the News Roundup, please contact CLIC Communications: or visit the CLIC Library to learn how to post  content to the CLIC website

The University of Rochester Center for Leading Innovation and Collaboration (CLIC) is the coordinating center for the Clinical and Translational Science Awards (CTSA) Program, funded by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), Grant U24TR002260.
Copyright © 2020 University of Rochester - CLIC, All rights reserved.
You are receiving this email because you are subscribed to an existing listserv. You may opt out at any time.

Our mailing address is:
University of Rochester - CLIC
265 Crittenden Blvd
Rochester, NY 14642-0001
Add us to your address book

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
University of Rochester - CLIC · 265 Crittenden Blvd · CU 420708 · Rochester, NY 14642-420708 · USA